Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.720
0.00 (0.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
Ikena Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 83 | 95 | 96 | 450 | - | - | |
Market Cap Growth | -71.36% | -1.43% | -78.58% | - | - | - | |
Enterprise Value | -53 | -59 | -72 | 212 | - | - | |
Last Close Price | 1.72 | 1.97 | 2.66 | 12.54 | - | - | |
PE Ratio | - | -1.21 | -1.40 | -10.29 | - | - | |
PS Ratio | 43.81 | 10.38 | 6.18 | 14.53 | - | - | |
PB Ratio | 0.58 | 0.56 | 0.66 | 2.17 | - | - | |
P/FCF Ratio | -1.09 | -1.19 | -1.28 | -7.26 | - | - | |
P/OCF Ratio | -1.10 | -1.19 | -1.30 | -7.47 | - | - | |
EV/Sales Ratio | -36.86 | -6.39 | -4.60 | 6.83 | - | - | |
EV/EBITDA Ratio | 0.95 | 0.79 | 1.02 | -6.30 | - | - | |
EV/EBIT Ratio | 0.94 | 0.78 | 1.01 | -6.20 | - | - | |
EV/FCF Ratio | 0.93 | 0.73 | 0.95 | -3.41 | - | - | |
Debt / Equity Ratio | 0.06 | 0.06 | 0.04 | 0.03 | 0.00 | - | |
Debt / FCF Ratio | -0.12 | -0.13 | -0.08 | -0.11 | 0.00 | - | |
Asset Turnover | 0.01 | 0.05 | 0.07 | 0.15 | 0.07 | 0.26 | |
Quick Ratio | 17.74 | 12.35 | 7.30 | 8.54 | 5.74 | 3.38 | |
Current Ratio | 18.22 | 12.58 | 7.44 | 8.70 | 5.86 | 3.51 | |
Return on Equity (ROE) | -44.54% | -43.04% | -38.76% | -21.81% | -72.35% | -98.52% | |
Return on Assets (ROA) | -27.41% | -25.87% | -21.10% | -10.25% | -21.88% | -21.67% | |
Return on Capital (ROIC) | -28.77% | -28.30% | -24.12% | -13.34% | -45.42% | -67.71% | |
Earnings Yield | -80.37% | -71.70% | -71.30% | -7.58% | - | - | |
FCF Yield | -87.81% | -84.32% | -78.32% | -13.77% | - | - | |
Buyback Yield / Dilution | -26.88% | -15.33% | -29.32% | -911.88% | -4.43% | -55.37% | |
Total Shareholder Return | -26.88% | -15.33% | -29.32% | -911.88% | -4.43% | -55.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.